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Previewsimplications for ESCRT-III function and
indicates that VPS4 activity is required
for membrane scission in vivo. In contrast,
in vitro experiments with giant unilamellar
vesicles and yeast ESCRT pathway
components showed that abscission of
vesicles depended only on ESCRT-III,
but not on Vps4 (Hurley and Hanson,
2010).
Several models have been brought
forward for ESCRT-III function, including
the stepwise removal of protomers from
circular ESCRT-III polymers leading to
membrane constriction and dome-like
ESCRT-III scaffolds promoting constric-
tion (Hurley and Hanson, 2010; Peel
et al., 2010). Baumga¨rtel and colleagues
suggest that the small number of VPS4
bursts per budding site and the delay
between those bursts and particle release
argue against a stepwise removal of
ESCRT-III components. The short resi-
dency of a few VPS4 dodecamers at the
budding site might be more consistent
with the dome-shaped ESCRT-III model
(Lata et al., 2008) supported by computa-
tional modeling (Fabrikant et al., 2009).
In this latter scenario, dodecameric174 Cell Host & Microbe 9, March 17, 2011 ªVPS4 might reinforce the ESCRT-III poly-
mer (Fabrikant et al., 2009), and/or the
ESCRT-III/VPS4 scaffold might keep
the membrane in a stressed state where
abrupt, ATPase activity-driven removal
might facilitate spontaneous fission (Peel
et al., 2010). Thus, the new findings re-
ported in these three papers will further
spark the hunt to define the minimal
mammalian ESCRT-III/VPS4 membrane
fission complex.ACKNOWLEDGMENTS
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While a polysaccharide capsule is known to be important for preventing phagocytosis of the humanpathogen
Cryptococcus neoformans, other antiphagocytic pathways have been generally elusive. Now, a capsule-
independent pathway has been identified that preventsmacrophages from ingesting the fungus, contributing
to evasion of the host immune response.Among the human fungal pathogens,
Cryptococcus neoformans is unique in its
ability to evade phagocytosis by macro-
phages. In a comprehensive analysis of
genes involved in preventing phagocy-
tosis, Chun et al. identify a pathway
responsible for aiding C. neoformans inevading the host immune response that
has implications for how all microbes
avoid immune detection (Chun et al.,
2011). In the case ofC. neoformans, inves-
tigating mechanisms of pathogenesis
is paramount because C. neoformans
is found worldwide and causes over600,000 deaths each year (Park et al.,
2009). People acquire C. neoformans
by inhaling infectious particles from the
environment and generally suffer no
apparent ill effects. However, immuno-
compromised individuals are susceptible
to developing severe, life-threatening
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Previewsdisease in the formofcryptococcalmenin-
goencephalitis. There is strong evidence
that cryptococcal disease is held at bay
by a robust innate immune response that
includes cell-mediated killing by macro-
phages (Voelz and May, 2010).
C. neoformans interactions with macro-
phages have been the subject of much
study because, unlike most microbes,
they are not readily phagocytosed by
phagocytes. This is observed easily in
cell culture where phagocytic cells gener-
ally ignore C. neoformans yeast unless
they have been opsonized (treated with
antibody or complement to facilitate
phagocytosis). An obvious culprit in
masking C. neoformans from macro-
phages is a polysaccharide capsule that
C. neoformans produces in response to
certain environmental conditions. This
capsule, composed of the complex poly-
saccharides glucuronoxylomannan and
galactoxylomannan, is a feat of nature
that can grow to many times the diameter
of a cell under the right conditions. Studies
of the role of capsule production in
C. neoformans pathogenesis over the last
20 years have revealed that this capsule
prevents phagocytosis of C. neoformans
by macrophages, regardless of its
diameter. This ‘‘antiphagocytic’’ activity
of thecapsule is a cornerstone of virulence
properties associated withC. neoformans
(Casadevall and Perfect, 1998).
Interestingly, however, this capsule is
not responsible for the whole story of
macrophage evasion by C. neoformans.
While it is true that strains that do not
produce a capsule can be more readily
phagocytosed by macrophages and
show defects in a mouse model of
cryptococcosis, human isolates of
C. neoformans that do not produce
capsule have been recovered (Chang
and Kwon-Chung, 1994; Torres et al.,
2005). The existence of virulent, acapsular
strains suggests that the capsule is not
a strict requirement for pathogenesis
and that other mechanisms to prevent
phagocytosis may exist. In fact, in 2003,
Luberto et al. discovered and character-
ized the secreted protein Antiphagocytic
protein 1 (App1) that functions via
complement receptors to block phagocy-
tosis in the presence or absence of a poly-saccharide capsule (Luberto et al., 2003).
In this case, the antiphagocytic activity of
App1 is apparent when the yeast are
opsonized. Now, Chun et al. have discov-
ered another antiphagocytosis pathway
independent of both capsule production
and App1 that functions in the absence
of opsonization.
In the manuscript, ‘‘A major role
for capsule-independent phagocytosis-
inhibitory mechanisms in mammalian
infection by Cryptococcus neoformans,’’
the authors identify and investigate the
influence of several genes that prevent
phagocytosis ofC. neoformans bymacro-
phages. In previous work, this group
showed that the transcription factor
Gat201 was important for virulence and
in preventing phagocytosis by macro-
phages in a manner that appeared inde-
pendent of capsule formation (Liu et al.,
2008). To follow this interesting lead, the
authors took a systematic and compre-
hensive approach to identify and charac-
terize several key direct targets involved
in this novel antiphagocytic pathway. The
authors use a variety of convergent
approaches, including gene expression
analysis, ChIP-chip analysis, a genetic
screen, phenotype analysis of deletion
strains, in vitro phagocytosis assays, and
a mouse model of lung colonization to
address this keyquestion inpathogenesis.
While these approaches in model
systems are often relatively straightfor-
ward, their applications in pathogens can
be extremely challenging. In this case,
chromatin immunoprecipitation optimiza-
tion was key in allowing a high-quality
molecular analysis of direct targets of
Gat201 in vivo inwhich theauthorsdiscov-
ered that two genes, BLP1 and GAT204,
contribute to a capsule-independent anti-
phagocytic pathway. BLP1 (encodes
a Barwin-like domain-containing protein)
andGAT204 (encodes aGATA family tran-
scription factor) are both direct targets of
Gat201 and when deleted individually
and in combination lead to increases in
phagocytosis by macrophages. This
findingwas underpinned by the very satis-
fying recovery of gat204 mutants from
a genetic screen for mutants more readily
phagocytosedbymacrophages in culture.
The authors topped off their analysis byCell Host & Microbeevaluating in vivo lung tissue burdens
using a mouse inhalation model of crypto-
coccosis. They discovered a correlation
between lung colonization and phagocy-
tosis in which strains with little ability to
colonize the lung were phagocytosed
in vitro. Conversely, strains resistant
to phagocytosis were easily recovered
from the lung, indicating an inverse rela-
tionship between phagocytosis and lung
persistence. This finding cements the
importance of this novel antiphagocytic
pathway in the ability of C. neoformans to
persist in the host.
Overall, the discoveries presented in
this new manuscript represent a substan-
tial advance to the Cryptococcus field
and provide an unprecedented molecular
foundation for understanding gene regula-
tion of complex behaviors. The authors
are now poised to carry out cell biological
and immunological studies to determine
the mechanisms by which BLP1 and
GAT204 contribute to the prevention of
phagocytosis by the host. These and
futurestudiesofGAT201pathwaycompo-
nents will not only advance our under-
standing of C. neoformans disease, but
also promise to enhance our under-
standing of host-pathogen interactions in
general.
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